Literature DB >> 31348742

Are there differences among bacillus Calmette-Guérin (BCG) strains regarding their clinical efficacy in the treatment of non-muscleinvasive bladder cancer? The jury is still out but the answer is likely no.

Guan Hee Tan1, Cynthia Kuk1,2, Alexandre R Zlotta1,2.   

Abstract

Entities:  

Year:  2019        PMID： 31348742      PMCID： PMC7012286          DOI： 10.5489/cuaj.5923

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  17 in total

1.  CUA guidelines on the management of non-muscle invasive bladder cancer.

Authors:  Wassim Kassouf; Samer L Traboulsi; Girish S Kulkarni; Rodney H Breau; Alexandre Zlotta; Andrew Fairey; Alan So; Louis Lacombe; Ricardo Rendon; Armen G Aprikian; D Robert Siemens; Jonathan I Izawa; Peter Black
Journal:  Can Urol Assoc J       Date:  2015-10-13       Impact factor: 1.862

Review 2.  BCG immunotherapy for bladder cancer--the effects of substrain differences.

Authors:  Christine Gan; Hugh Mostafid; Muhammad Shamim Khan; David J M Lewis
Journal:  Nat Rev Urol       Date:  2013-09-17       Impact factor: 14.432

Review 3.  Evolution and Strain Variation in BCG.

Authors:  Abdallah M Abdallah; Marcel A Behr
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

4.  All bacillus Calmette-Guérin (BCG) strains are equal, but some BCG strains are more equal than others.

Authors:  Aidan P Noon; Girish S Kulkarni
Journal:  Eur Urol       Date:  2014-04-28       Impact factor: 20.096

5.  What are the immunologically active components of bacille Calmette-Guérin in therapy of superficial bladder cancer?

Authors:  A R Zlotta; J P Van Vooren; O Denis; A Drowart; M Daffé; P Lefèvre; L Schandene; M De Cock; J De Bruyn; P Vandenbussche; F Jurion; K Palfliet; J Simon; C C Schulman; J Content; K Huygen
Journal:  Int J Cancer       Date:  2000-09-15       Impact factor: 7.396

6.  Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.

Authors:  Roger Chou; Shelley Selph; David I Buckley; Rongwei Fu; Jessica C Griffin; Sara Grusing; John L Gore
Journal:  J Urol       Date:  2016-12-24       Impact factor: 7.450

7.  Connaught and Russian strains showed the highest direct antitumor effects of different Bacillus Calmette-Guérin substrains.

Authors:  Silvia Secanella-Fandos; Marina Luquin; Esther Julián
Journal:  J Urol       Date:  2012-10-08       Impact factor: 7.450

Review 8.  The mechanism of action of BCG therapy for bladder cancer--a current perspective.

Authors:  Gil Redelman-Sidi; Michael S Glickman; Bernard H Bochner
Journal:  Nat Rev Urol       Date:  2014-02-04       Impact factor: 14.432

9.  Genomic expression catalogue of a global collection of BCG vaccine strains show evidence for highly diverged metabolic and cell-wall adaptations.

Authors:  Abdallah M Abdallah; Grant A Hill-Cawthorne; Thomas D Otto; Francesc Coll; José Afonso Guerra-Assunção; Ge Gao; Raeece Naeem; Hifzur Ansari; Tareq B Malas; Sabir A Adroub; Theo Verboom; Roy Ummels; Huoming Zhang; Aswini Kumar Panigrahi; Ruth McNerney; Roland Brosch; Taane G Clark; Marcel A Behr; Wilbert Bitter; Arnab Pain
Journal:  Sci Rep       Date:  2015-10-21       Impact factor: 4.379

Review 10.  Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis.

Authors:  A Roy; M Eisenhut; R J Harris; L C Rodrigues; S Sridhar; S Habermann; L Snell; P Mangtani; I Adetifa; A Lalvani; I Abubakar
Journal:  BMJ       Date:  2014-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.